Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents.
Saved in:
| Title: | Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents. |
|---|---|
| Authors: | Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Scalise L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cacciapuoti MT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA., Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Stathis A; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland., Van Berkel PH; ADC Therapeutics (UK) Ltd., London, UK., Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA., Zammarchi F; ADC Therapeutics (UK) Ltd., London, UK., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. |
| Source: | British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1873-1882. Date of Electronic Publication: 2024 Jul 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39080847 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Spriano+F%22">Spriano F</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tarantelli+C%22">Tarantelli C</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cascione+L%22">Cascione L</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gaudio+E%22">Gaudio E</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Golino+G%22">Golino G</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Scalise+L%22">Scalise L</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cacciapuoti+MT%22">Cacciapuoti MT</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Zucca+E%22">Zucca E</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Stathis+A%22">Stathis A</searchLink>; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Van+Berkel+PH%22">Van Berkel PH</searchLink>; ADC Therapeutics (UK) Ltd., London, UK.<br /><searchLink fieldCode="AU" term="%22Inghirami+G%22">Inghirami G</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Zammarchi+F%22">Zammarchi F</searchLink>; ADC Therapeutics (UK) Ltd., London, UK.<br /><searchLink fieldCode="AU" term="%22Bertoni+F%22">Bertoni F</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1873-1882. <i>Date of Electronic Publication: </i>2024 Jul 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39080847 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.19658 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1873 Titles: – TitleFull: Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Spriano F – PersonEntity: Name: NameFull: Tarantelli C – PersonEntity: Name: NameFull: Cascione L – PersonEntity: Name: NameFull: Gaudio E – PersonEntity: Name: NameFull: Golino G – PersonEntity: Name: NameFull: Scalise L – PersonEntity: Name: NameFull: Cacciapuoti MT – PersonEntity: Name: NameFull: Zucca E – PersonEntity: Name: NameFull: Stathis A – PersonEntity: Name: NameFull: Van Berkel PH – PersonEntity: Name: NameFull: Inghirami G – PersonEntity: Name: NameFull: Zammarchi F – PersonEntity: Name: NameFull: Bertoni F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2024 Nov Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 205 – Type: issue Value: 5 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |